Names of 11 companies from Jiangsu appeared on the list of 2020 Top Chinese Pharmaceutical Companies announced at the 38th National Annual Conference on Pharmaceutical Industry Information, according to Jiangsu Provincial Department of Industry and Information Technology.
Statistics and analysis provided by China National Pharmaceutical Industry Information Center showed that in 2020, prime operating revenue of the top 100 drug companies registered RMB 901.21 billion, down by 3.1% year-on-year, marking the first ever negative growth in recent ten years, mainly due to the impact of COVID-19 compounded by other factors. In terms of R&D input, the average expenditure of the top 100 companies reached RMB 633 million, with an average R&D intensity of 6.8%, a record high. According to this latest ranking, Yangtze River Pharmaceutical Group Co., Ltd. was in second place, whereas China National Pharmaceutical Group Co., Ltd. (Sinopharm), ranking third last year, rose to the top. It was quite noticeable that Jiangsu Hengrui Pharma, last year only in 10th place, leaped to the fourth. AstraZeneca Pharmaceutical Co., Ltd. and Chiatai Tianqing (CTTQ) ranked 14th and 15th respectively.